Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001071767 | SCV001237088 | likely benign | Brugada syndrome | 2024-10-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348490 | SCV002621433 | benign | Cardiovascular phenotype | 2021-04-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV003480952 | SCV004226082 | uncertain significance | not provided | 2022-03-15 | criteria provided, single submitter | clinical testing | BS2 |